A large U.S. study found that people assigned female at birth with polyendocrine metabolic ovarian syndrome (PMOS), the condition formerly called polycystic ovary syndrome (PCOS), face…
Skin cancer is the most common cancer in the U.S., but its earliest signs aren’t always obvious.
Skin cancer is common but often caught when it’s already advanced because many early clues don’t look like a suspicious mole.
Federal regulators have begun reviewing applications from Swiss drugmaker Sandoz to develop generic versions of tirzepatide medicines sold as Mounjaro and Zepbound.
Carrie Ann Inaba, longtime judge on Dancing with the Stars, has shared how she struggled for years with unexplained symptoms before learning she had Sjögren’s disease.
A new biweekly GLP-1 injection, bofanglutide, reduced blood sugar and produced weight loss in a phase 2b randomized clinical trial, offering a potential alternative to once-weekly…
A large new study links long uninterrupted periods of sitting or lying down to a higher risk of several cancers — but even brief, light movement can make a meaningful difference.
The FDA has cleared EchoNext, the first artificial intelligence tool designed to detect underlying structural heart disease from routine electrocardiograms (ECGs).
A recent large observational study suggests that GLP-1 receptor agonist (GLP-1RA) medications — widely used for type 2 diabetes and increasingly for weight loss — may be linked with a…
Starting July 1, Medicare will launch a new pilot program that lets many Part D beneficiaries buy certain GLP‑1 weight‑loss medications for $50 per month.
In 2000, while finishing her junior year at Michigan State University, Jayme Cohen Lynde felt a small lump on the side of her neck.